Arcutis Biotherapeutics, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arcutis Biotherapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Arcutis Biotherapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -145 %, a 23% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Return On Equity for 2023 was -295 %, a 120% decline from 2022.
  • Arcutis Biotherapeutics, Inc. annual Return On Equity for 2022 was -134 %, a 148% decline from 2021.
  • Arcutis Biotherapeutics, Inc. annual Return On Equity for 2021 was -54.1 %, a 10.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -295 -161 -120% Jan 1, 2023 Dec 31, 2023
2022 -134 -80 -148% Jan 1, 2022 Dec 31, 2022
2021 -54.1 +6.59 +10.9% Jan 1, 2021 Dec 31, 2021
2020 -60.7 -150 -168% Jan 1, 2020 Dec 31, 2020
2019 89.8 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.